Dry eye sufferers get lasting relief with repeat TearCare treatment
NCT ID NCT03804502
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 30 times
Summary
This study looked at whether retreating with the TearCare system is safe and effective for adults with dry eye syndrome who had already been treated once before. Twelve people took part, and researchers measured tear film stability and meibomian gland function one month after retreatment. The goal was to see if the treatment could provide ongoing symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROMES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Central Eye Care
Arlington Heights, Illinois, 60005, United States
Conditions
Explore the condition pages connected to this study.